A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2019
At a glance
- Drugs Binimetinib (Primary)
- Indications Neurofibroma; Neurofibromatoses
- Focus Therapeutic Use
- Acronyms NF108-BINI
- 20 Dec 2017 Status changed from not yet recruiting to recruiting.
- 17 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.
- 14 Feb 2017 New trial record